A Randomized, Double-Blind, Placebo-Controlled Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea
Latest Information Update: 12 Dec 2011
Price :
$35 *
At a glance
- Drugs ATx08 001 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Astellas Pharma US; Fujisawa Health Care
- 12 Dec 2011 New trial record